Tag: Announces

Posted on

ALK announces top-line results from the five-year landmark GRAZAX® Asthma … – GlobeNewswire (press release)

ALK announces top-line results from the five-year landmark GRAZAX® Asthma …
GlobeNewswire (press release)
The trial did not show an effect in terms of time to first diagnosis of reversible impairment of lung function. The trial demonstrated that GRAZAX® treatment significantly reduced the proportion of children experiencing asthma symptoms or using asthma …
BRIEF-Alk Abello announces results from GRAZAX Asthma Prevention trial in childrenReuters
ALK announces top-line results from the five-year landmark GRAZAX(r) Asthma …EconoTimes

all 6 news articles »

View full post on asthma – Google News

Posted on

ALK announces top-line results from the five-year landmark GRAZAX(r) Asthma … – EconoTimes

ALK announces top-line results from the five-year landmark GRAZAX(r) Asthma …
EconoTimes
In contrast, treatment with GRAZAX(r) had a positive effect on the children's asthma symptoms and use of asthma medication. The odds ratio (secondary endpoint) for experiencing asthma symptoms[1] or using asthma medication[2], at the end of the five …

and more »

View full post on asthma – Google News

Posted on

Meda Pharmaceuticals Announces Launch of Part 3 of the Medikidz Explain Asthma … – PR Newswire (press release)


PR Newswire (press release)

Meda Pharmaceuticals Announces Launch of Part 3 of the Medikidz Explain Asthma …
PR Newswire (press release)
SOMERSET, N.J., Nov. 5, 2015 /PRNewswire/ — Meda Pharmaceuticals (Meda), a leading international specialty pharmaceutical company, announces the launch of Part 3 of the Medikidz Explain Asthma Series, the latest comic book to help families gain an …

View full post on asthma – Google News

Posted on

Teva Announces European Medicines Agency (EMA) Confirms Successful Validation … – MarketWatch

Teva Announces European Medicines Agency (EMA) Confirms Successful Validation …
MarketWatch
“Uncontrolled asthma remains a serious challenge for patients and healthcare professionals despite the availability of standard of care treatment,” said Dr. Michael Hayden, President of Global R&D and Chief Scientific Officer at Teva Pharmaceutical …

and more »

View full post on asthma – Google News

Posted on

Allergy & Asthma Network Announces Free Webinar on Stinging Insect Allergy … – PR Newswire (press release)


CBS News

Allergy & Asthma Network Announces Free Webinar on Stinging Insect Allergy …
PR Newswire (press release)
VIENNA, Va., July 1, 2015 /PRNewswire-USNewswire/ — Allergy & Asthma Network, a leading nonprofit patient education organization, invites you to join its "2015 Stinging Insect Allergy & Anaphylaxis" webinar with David Golden, MD, board-certified …
Some sunscreen ingredients can cause allergiesCBS News

all 2 news articles »

View full post on asthma – Google News

Posted on

Asthma and Allergy Foundation Announces Sponsorship of Institute of Medicine … – Benzinga

Asthma and Allergy Foundation Announces Sponsorship of Institute of Medicine …
Benzinga
To address these gaps in knowledge, research and data, the Asthma and Allergy Foundation of America (AAFA) announces its co-sponsorship of a new Institute of Medicine (IOM) consensus study on food allergy. The study, "Food Allergies: Global Burden, …

and more »

View full post on asthma – Google News

Posted on

Teva Announces FDA Acceptance of Reslizumab For Asthma – Lung Disease News


Lung Disease News

Teva Announces FDA Acceptance of Reslizumab For Asthma
Lung Disease News
Reslizumab is being developed as treatment of inadequately controlled asthma in adults and young people who have increased blood eosinophils, despite being under treatment with an inhaled corticosteroid (ICS) drug regimen. “Despite currently available …
FDA to review Teva asthma biologicBioPharma Dive
FDA will review Teva's asthma biologic reslizumabPharmaTimes
Stock Update (NYSE:TEVA): Teva Pharmaceuticals Industries Ltd (ADR …Smarter Analyst
PMLiVE
all 20 news articles »

View full post on asthma – Google News

Posted on

GlaxoSmithKline (GSK), Theravance (THRX) Announces US FDA Approval of … – StreetInsider.com

GlaxoSmithKline (GSK), Theravance (THRX) Announces US FDA Approval of …
StreetInsider.com
GlaxoSmithKline (NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) announced that the US Food and Drug Administration (FDA) has approved BREO ELLIPTA (fluticasone furoate/vilanterol [FF/VI]) for the once-daily treatment of asthma in patients aged 18 …
Glaxo Wins U.S. Approval to Sell Breo Only to Adults With AsthmaBloomberg
FDA approves Glaxo's inhaler drug Breo Ellipta for new use in treating adults …Minneapolis Star Tribune

all 2 news articles »

View full post on asthma – Google News

Posted on

Allergy & Asthma Network Announces Free Webinar on Allergic Reactions to … – MarketWatch

Allergy & Asthma Network Announces Free Webinar on Allergic Reactions to …
MarketWatch
VIENNA, Va., July 10, 2014 /PRNewswire-USNewswire/ — Allergy & Asthma Network, a leading nonprofit patient education organization, invites you to join its "2014 Venom Allergy 101" webinar on July 24, 2014, at 7 p.m. EST. This webinar is perfect for …
Allergy & Asthma Network, ALAA to increase awareness on life-threatening latex …News-Medical.net
Sports Breathing Issues – Asthma or Not?Allergic Living
Is an Allergy Shot Worth It?fox2now.com
Palm Beach Post
all 25 news articles »

View full post on asthma – Google News